:@0.085519:0.075583:0.090751:0.075583:0.090751:0.059604:0.085519:0.059604:0.005232
 :@0.621674:0.075583:0.626906:0.075583:0.626906:0.059604:0.621674:0.059604:0.005232
 :@0.884977:0.940183:0.890322:0.940183:0.890322:0.922163:0.884977:0.922163:0.005345
Oral Presenter Abstract :@0.736982:0.075583:0.918858:0.075583:0.918858:0.059604:0.736982:0.059604:0.011658:0.006331:0.008492:0.004000:0.005293:0.010369:0.006331:0.008929:0.008569:0.008929:0.009573:0.005251:0.008929:0.006382:0.005321:0.010407:0.009403:0.008511:0.005289:0.006275:0.008531:0.008531:0.005340:0.005232
OD-11 :@0.083238:0.078822:0.159838:0.078822:0.159838:0.060055:0.083238:0.060055:0.018529:0.017104:0.007982:0.013255:0.013113:0.006617
Expression of Tumor Necrosis Factor Receptor 2 (TNFR2) and Ki-67 in :@0.127708:0.158311:0.878833:0.158311:0.878833:0.136326:0.127708:0.136326:0.013094:0.011685:0.013537:0.008686:0.013120:0.011842:0.011842:0.006651:0.013120:0.013355:0.006573:0.013042:0.007329:0.006521:0.013146:0.013355:0.019693:0.013042:0.008738:0.006521:0.016145:0.013068:0.011816:0.008686:0.013042:0.011842:0.006651:0.011842:0.006521:0.013094:0.012729:0.011816:0.007668:0.013120:0.008686:0.006521:0.015415:0.013068:0.011868:0.013068:0.013537:0.007668:0.013172:0.008686:0.006521:0.013120:0.006521:0.008686:0.013120:0.016145:0.012937:0.015415:0.013042:0.008686:0.006599:0.012650:0.013355:0.013589:0.006521:0.014528:0.007196:0.008694:0.013042:0.013042:0.006521:0.006703:0.013355:0.006521
Sporadic Young-Onset Colorectal Cancer (CRC) in a Single Tertiary Center :@0.105758:0.182399:0.900763:0.182399:0.900763:0.160414:0.105758:0.160414:0.014398:0.013537:0.013042:0.008738:0.012650:0.013537:0.006703:0.011816:0.006521:0.014398:0.013146:0.013355:0.013407:0.013700:0.008694:0.016041:0.013433:0.011842:0.013068:0.007668:0.006599:0.014294:0.013042:0.006651:0.013042:0.008686:0.013068:0.011816:0.007747:0.012650:0.006703:0.006521:0.014294:0.012650:0.013355:0.011868:0.012963:0.008686:0.006521:0.008686:0.014294:0.015520:0.014294:0.008686:0.006521:0.006651:0.013433:0.006521:0.012650:0.006868:0.014398:0.006651:0.013407:0.013511:0.006651:0.013172:0.006521:0.013120:0.013068:0.008686:0.007721:0.006547:0.012650:0.008686:0.011685:0.006573:0.014294:0.013068:0.013355:0.007668:0.013172:0.008911:0.006521
Nurul Hakimah Mohd Salim , Andee Dzulkarnaen Zakaria , Wan Faiziah Wan Abdul :@0.108324:0.224794:0.898114:0.224794:0.898114:0.204731:0.108324:0.204731:0.014662:0.011925:0.007950:0.011925:0.004951:0.006450:0.014639:0.010664:0.010592:0.004880:0.018495:0.010545:0.011901:0.006474:0.018638:0.011901:0.011759:0.011901:0.006570:0.013139:0.010664:0.004951:0.004808:0.018447:0.007323:0.005951:0.006450:0.013139:0.011925:0.011901:0.011211:0.011211:0.006450:0.014662:0.009164:0.011925:0.004951:0.010592:0.010568:0.007831:0.011925:0.010711:0.011116:0.011925:0.006570:0.011925:0.010664:0.010521:0.010664:0.007855:0.004951:0.010664:0.017972:0.005855:0.006570:0.018923:0.010664:0.011997:0.006570:0.010687:0.010664:0.004951:0.009164:0.004880:0.010664:0.011973:0.006403:0.018804:0.010664:0.011973:0.006570:0.013139:0.011782:0.011901:0.011925:0.004951:0.006570
1:@0.367351:0.217530:0.374477:0.217530:0.374477:0.205516:0.367351:0.205516:0.007127
2,4:@0.642056:0.217530:0.659873:0.217530:0.659873:0.205516:0.642056:0.205516:0.007127:0.003563:0.007127
Rahman , Rohimah Mohamud , Siti Norasikin Mohd Nafi  and Nur Asyilla Che Jalil * :@0.093928:0.246664:0.912784:0.246664:0.912784:0.226601:0.093928:0.226601:0.013663:0.010664:0.011901:0.018447:0.010664:0.011925:0.017852:0.005951:0.006570:0.013568:0.011901:0.011759:0.004951:0.018447:0.010664:0.011949:0.006403:0.018590:0.011901:0.011901:0.010664:0.018352:0.011830:0.011901:0.007232:0.005951:0.006570:0.013139:0.004951:0.006450:0.004951:0.006570:0.014567:0.011901:0.007950:0.010664:0.010687:0.004951:0.010592:0.004832:0.011925:0.006570:0.018590:0.011806:0.011901:0.012020:0.006403:0.014662:0.010664:0.006689:0.004951:0.007145:0.006556:0.010545:0.011925:0.011997:0.006403:0.014662:0.011925:0.008021:0.006570:0.012949:0.010687:0.010664:0.004880:0.004951:0.004951:0.010664:0.006379:0.013258:0.011901:0.011306:0.006403:0.010664:0.010664:0.004951:0.004951:0.004951:0.021544:0.009265:0.006570
1,4:@0.171228:0.239401:0.189044:0.239401:0.189044:0.227387:0.171228:0.227387:0.007127:0.003563:0.007127
3:@0.386450:0.239401:0.393577:0.239401:0.393577:0.227387:0.386450:0.227387:0.007127
1:@0.634645:0.239401:0.641771:0.239401:0.641771:0.227387:0.634645:0.227387:0.007127
1,4,:@0.875570:0.239401:0.896950:0.239401:0.896950:0.227387:0.875570:0.227387:0.007127:0.003563:0.007127:0.003563
1:@0.100342:0.280453:0.106217:0.280453:0.106217:0.269400:0.100342:0.269400:0.005875
 Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kubang :@0.106186:0.286720:0.904789:0.286720:0.904789:0.268699:0.106186:0.268699:0.005416:0.011780:0.008766:0.009578:0.008231:0.006072:0.004725:0.014367:0.008766:0.009514:0.004661:0.005430:0.009578:0.004532:0.005388:0.010626:0.008231:0.004661:0.009557:0.009578:0.004276:0.009578:0.009493:0.008274:0.004682:0.005409:0.010690:0.008295:0.009514:0.009578:0.009578:0.004276:0.005345:0.009578:0.004682:0.005409:0.015308:0.008637:0.009578:0.004276:0.008295:0.008231:0.004276:0.005345:0.010690:0.008295:0.004276:0.008830:0.009557:0.008295:0.008659:0.008253:0.004682:0.005580:0.011802:0.009621:0.004276:0.008231:0.008680:0.006072:0.008295:0.004276:0.004661:0.004276:0.005430:0.010690:0.008231:0.004276:0.009621:0.008253:0.005345:0.015308:0.008124:0.004276:0.008231:0.008274:0.008253:0.004276:0.008295:0.005388:0.011802:0.008766:0.008231:0.004276:0.004661:0.009621:0.005345:0.011823:0.008167:0.014367:0.009578:0.009599:0.008253:0.004682:0.005345:0.010604:0.009599:0.009493:0.008231:0.009621:0.009557:0.005345
Kerian, Kelantan, Malaysia :@0.401701:0.304962:0.603787:0.304962:0.603787:0.286941:0.401701:0.286941:0.010604:0.008637:0.006072:0.004276:0.008295:0.009557:0.004682:0.005409:0.010604:0.008637:0.004276:0.008231:0.009621:0.004661:0.008231:0.009621:0.004682:0.005345:0.015308:0.008231:0.004276:0.008295:0.008274:0.008253:0.004276:0.008386:0.005345
2 :@0.109179:0.317038:0.118301:0.317038:0.118301:0.305986:0.109179:0.305986:0.005844:0.003278
Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kubang :@0.118301:0.323305:0.895988:0.323305:0.895988:0.305285:0.118301:0.305285:0.011780:0.008766:0.009578:0.008231:0.006072:0.004725:0.014367:0.008766:0.009514:0.004661:0.005430:0.009578:0.004682:0.005345:0.010690:0.009471:0.006072:0.009557:0.008766:0.006072:0.008274:0.004682:0.005452:0.010690:0.008295:0.009514:0.009578:0.009578:0.004276:0.005345:0.009578:0.004682:0.005409:0.015115:0.008702:0.009578:0.004276:0.008295:0.008231:0.004276:0.005345:0.010690:0.008295:0.004276:0.008766:0.009493:0.008381:0.008702:0.008253:0.004682:0.005430:0.011802:0.009621:0.004276:0.008231:0.008680:0.006072:0.008295:0.004276:0.004661:0.004276:0.005430:0.010690:0.008231:0.004276:0.009621:0.008253:0.005345:0.015308:0.008231:0.004169:0.008231:0.008274:0.008253:0.004276:0.008295:0.005388:0.011802:0.008766:0.008231:0.004276:0.004661:0.009621:0.005345:0.011823:0.008167:0.014367:0.009578:0.009599:0.008253:0.004682:0.005345:0.010604:0.009599:0.009493:0.008231:0.009621:0.009557:0.005345
Kerian, Kelantan, Malaysia :@0.401701:0.341547:0.603787:0.341547:0.603787:0.323527:0.401701:0.323527:0.010604:0.008637:0.006072:0.004276:0.008295:0.009557:0.004682:0.005409:0.010604:0.008637:0.004276:0.008231:0.009621:0.004661:0.008231:0.009621:0.004682:0.005345:0.015308:0.008231:0.004276:0.008295:0.008274:0.008253:0.004276:0.008386:0.005345
3 :@0.091648:0.353523:0.100770:0.353523:0.100770:0.342470:0.091648:0.342470:0.005844:0.003278
Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kubang :@0.100770:0.359790:0.913742:0.359790:0.913742:0.341769:0.100770:0.341769:0.011780:0.008766:0.009578:0.008231:0.006072:0.004725:0.014367:0.008766:0.009514:0.004661:0.005430:0.009578:0.004682:0.005259:0.004789:0.014367:0.014367:0.009514:0.009557:0.009578:0.004276:0.009578:0.009493:0.008274:0.004682:0.005409:0.010690:0.008295:0.009514:0.009664:0.009578:0.004276:0.005345:0.009578:0.004682:0.005430:0.015308:0.008637:0.009578:0.004276:0.008295:0.008231:0.004276:0.005345:0.010690:0.008295:0.004276:0.008766:0.009493:0.008381:0.008808:0.008253:0.004682:0.005739:0.011802:0.009621:0.004276:0.008231:0.008680:0.006072:0.008295:0.004276:0.004661:0.004169:0.005388:0.010690:0.008231:0.004276:0.009621:0.008253:0.005259:0.015308:0.008231:0.004276:0.008231:0.008274:0.008253:0.004276:0.008231:0.005452:0.011802:0.008766:0.008231:0.004276:0.004661:0.009621:0.005345:0.011823:0.008167:0.014367:0.009578:0.009599:0.008253:0.004682:0.005345:0.010604:0.009599:0.009493:0.008231:0.009621:0.009557:0.005345
Kerian, Kelantan, Malaysia :@0.401701:0.378133:0.603787:0.378133:0.603787:0.360112:0.401701:0.360112:0.010604:0.008637:0.006072:0.004276:0.008295:0.009557:0.004682:0.005409:0.010604:0.008637:0.004276:0.008231:0.009621:0.004661:0.008231:0.009621:0.004682:0.005345:0.015308:0.008231:0.004276:0.008295:0.008274:0.008253:0.004276:0.008386:0.005345
4:@0.235937:0.390108:0.241812:0.390108:0.241812:0.379056:0.235937:0.379056:0.005875
Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia :@0.241781:0.396375:0.769551:0.396375:0.769551:0.378354:0.241781:0.378354:0.011802:0.009578:0.008253:0.009578:0.004276:0.004661:0.008231:0.004276:0.005452:0.011802:0.009621:0.004276:0.008231:0.008680:0.006072:0.008295:0.004276:0.004661:0.004169:0.005388:0.010690:0.008231:0.004276:0.009621:0.008253:0.005345:0.015308:0.008231:0.004276:0.008231:0.008274:0.008295:0.004276:0.008231:0.004597:0.005388:0.010604:0.009493:0.009578:0.008231:0.009557:0.009557:0.005345:0.010604:0.008702:0.006072:0.004276:0.008295:0.009557:0.004682:0.005409:0.010604:0.008637:0.004276:0.008381:0.009557:0.004661:0.008295:0.009557:0.004682:0.005409:0.015308:0.008231:0.004276:0.008231:0.008274:0.008253:0.004276:0.008457:0.005345
*Corresponding Author: asyilla@usm.my :@0.345686:0.434909:0.659801:0.434909:0.659801:0.416888:0.345686:0.416888:0.008188:0.011823:0.009493:0.006072:0.006157:0.008702:0.008253:0.009578:0.009578:0.009514:0.009578:0.004361:0.009557:0.009557:0.005345:0.010733:0.009599:0.004661:0.009535:0.009578:0.006072:0.004682:0.005578:0.008231:0.008253:0.008274:0.004276:0.004276:0.004276:0.008295:0.017147:0.009514:0.008253:0.014367:0.004725:0.014367:0.008324:0.005345
Colorectal cancer (CRC) is currently the second leading cause of cancer-related death, :@0.171085:0.475382:0.920470:0.475382:0.920470:0.455319:0.171085:0.455319:0.013163:0.010664:0.004689:0.010664:0.006760:0.009664:0.009236:0.005189:0.009164:0.004642:0.007950:0.009236:0.009164:0.010711:0.009236:0.009688:0.006760:0.007902:0.006689:0.013163:0.012068:0.013163:0.006689:0.007926:0.004761:0.009188:0.007831:0.009236:0.010687:0.006760:0.006665:0.009759:0.010616:0.005189:0.004642:0.009212:0.008021:0.005189:0.010640:0.009759:0.007902:0.009236:0.009759:0.009236:0.010664:0.010545:0.010664:0.007974:0.004570:0.009759:0.009045:0.010664:0.004761:0.010711:0.010640:0.007950:0.009236:0.009164:0.010687:0.009188:0.009616:0.007950:0.010545:0.005213:0.007879:0.009236:0.009164:0.010711:0.009236:0.009688:0.006994:0.007982:0.006760:0.009640:0.004761:0.009069:0.005260:0.009759:0.010664:0.007926:0.010545:0.009759:0.009045:0.005189:0.010711:0.005451:0.005951
with increasing prevalence among younger individuals. To date, the prevalence of CRC among young :@0.085519:0.498764:0.920376:0.498764:0.920376:0.478701:0.085519:0.478701:0.013377:0.004761:0.005094:0.010711:0.004689:0.004761:0.010640:0.009236:0.006760:0.009664:0.009164:0.009188:0.004761:0.010711:0.010640:0.004713:0.010545:0.006760:0.009640:0.009164:0.009069:0.004832:0.009759:0.010616:0.009236:0.009759:0.004665:0.009164:0.015924:0.010664:0.010711:0.010640:0.004761:0.009212:0.010711:0.010687:0.010711:0.010640:0.009759:0.006665:0.004713:0.004761:0.010640:0.010664:0.004761:0.009093:0.004761:0.010664:0.010521:0.009164:0.004665:0.009236:0.005213:0.004761:0.010545:0.010664:0.004737:0.010664:0.009164:0.005118:0.009759:0.005213:0.004689:0.005189:0.010640:0.009759:0.004642:0.010545:0.006760:0.009640:0.009164:0.009069:0.004832:0.009759:0.010616:0.009236:0.009759:0.004665:0.010664:0.005284:0.004713:0.013163:0.012068:0.013163:0.004665:0.009164:0.015924:0.010664:0.010711:0.010640:0.004761:0.009117:0.010664:0.010687:0.010711:0.010545:0.005951
individuals has become alarming. The roles of Tumour Necrosis Factor Receptor 2 (TNFR2) and Ki-:@0.085519:0.522146:0.914735:0.522146:0.914735:0.502084:0.085519:0.502084:0.004761:0.010640:0.010664:0.004761:0.009093:0.004761:0.010664:0.010687:0.009164:0.004642:0.009236:0.005855:0.010711:0.009164:0.009069:0.005855:0.010545:0.009759:0.009236:0.010664:0.015995:0.009640:0.005855:0.009164:0.004665:0.009164:0.006665:0.015995:0.004665:0.010711:0.010640:0.005284:0.005713:0.010640:0.010711:0.009759:0.005808:0.006760:0.010664:0.004665:0.009759:0.009045:0.005855:0.010545:0.005213:0.005760:0.010640:0.010687:0.015876:0.010664:0.010687:0.006760:0.005808:0.013139:0.009664:0.009236:0.006760:0.010521:0.009236:0.004761:0.009069:0.005855:0.010664:0.009164:0.009117:0.005189:0.010664:0.006665:0.005855:0.012163:0.009640:0.009338:0.009759:0.010664:0.005094:0.010664:0.006760:0.005808:0.010545:0.005855:0.006689:0.010568:0.013139:0.010664:0.012163:0.010664:0.006546:0.005855:0.009164:0.010711:0.010664:0.005665:0.011806:0.004729:0.007950
67 in modulating the disease prognosis have gained much attention from researchers. TNFR2 is :@0.085519:0.545529:0.920043:0.545529:0.920043:0.525466:0.085519:0.525466:0.010664:0.010664:0.008164:0.004761:0.010497:0.008093:0.015995:0.010664:0.010664:0.010687:0.004761:0.009093:0.005189:0.004642:0.010711:0.010521:0.008093:0.005189:0.010640:0.009759:0.008045:0.010664:0.004761:0.009188:0.009759:0.009164:0.009188:0.009569:0.008093:0.010664:0.006760:0.010521:0.010640:0.010711:0.010568:0.009236:0.004761:0.009188:0.007974:0.010711:0.009164:0.009069:0.009759:0.008045:0.010640:0.009164:0.004761:0.010711:0.009616:0.010664:0.008117:0.015995:0.010687:0.009236:0.010545:0.008093:0.009164:0.005094:0.005189:0.009640:0.010711:0.005118:0.004761:0.010759:0.010711:0.008069:0.005213:0.006760:0.010664:0.015853:0.008093:0.006760:0.009640:0.009236:0.009759:0.009045:0.006760:0.009236:0.010521:0.009759:0.006641:0.009236:0.005213:0.008021:0.010640:0.013139:0.010664:0.012163:0.010545:0.008093:0.004761:0.009069:0.005951
found in tumor cells and tumor-infiltrating lymphocytes (TILs), which include immune-suppressing :@0.085519:0.568810:0.920517:0.568810:0.920517:0.548748:0.085519:0.548748:0.005213:0.010735:0.010687:0.010711:0.010521:0.006379:0.004761:0.010640:0.006379:0.005189:0.010687:0.015900:0.010664:0.006593:0.006379:0.009117:0.009759:0.004642:0.004761:0.009188:0.006403:0.009164:0.010711:0.010664:0.006355:0.005189:0.010687:0.015900:0.010664:0.006951:0.007982:0.004761:0.010497:0.005213:0.004761:0.004761:0.005070:0.006760:0.009069:0.005260:0.004761:0.010640:0.010640:0.006450:0.004761:0.009212:0.015995:0.010664:0.010711:0.010521:0.009117:0.009212:0.005189:0.009688:0.009236:0.006379:0.006546:0.010640:0.005332:0.010545:0.009188:0.006689:0.005213:0.006236:0.013377:0.010711:0.004761:0.009069:0.010711:0.006379:0.004761:0.010640:0.009236:0.004761:0.010687:0.010664:0.009759:0.006331:0.004761:0.015900:0.015995:0.010687:0.010521:0.009884:0.007982:0.009236:0.010687:0.010664:0.010664:0.006760:0.009688:0.009188:0.009188:0.004761:0.010711:0.010640:0.005951
Tregs. It is often linked to cytokines that cause inflammation. This receptor expression can trigger :@0.085519:0.592193:0.920298:0.592193:0.920298:0.572130:0.085519:0.572130:0.010640:0.006760:0.009688:0.010640:0.009188:0.005213:0.007141:0.005332:0.005070:0.007093:0.004761:0.009188:0.007117:0.010545:0.005213:0.005189:0.009759:0.010616:0.007093:0.004761:0.004642:0.010711:0.009164:0.009640:0.010664:0.007141:0.005189:0.010664:0.007069:0.009236:0.009259:0.005189:0.010664:0.009093:0.004761:0.010640:0.009759:0.009188:0.007117:0.005189:0.010640:0.009164:0.005340:0.007127:0.009236:0.009164:0.010687:0.009188:0.009759:0.007093:0.004761:0.010640:0.005213:0.004761:0.009164:0.015995:0.015900:0.009164:0.005094:0.004761:0.010664:0.010711:0.005213:0.007117:0.010640:0.010711:0.004761:0.009188:0.007141:0.006546:0.009759:0.009236:0.009664:0.010664:0.005189:0.010664:0.006760:0.007046:0.009759:0.009474:0.010664:0.006760:0.009664:0.009236:0.009236:0.004570:0.010664:0.010711:0.007117:0.009236:0.009164:0.010711:0.007069:0.005189:0.006641:0.004761:0.010640:0.010640:0.009759:0.006665:0.005951
the release of inflammatory cytokines and enhance the activity of immunosuppressive cells, allowing :@0.085519:0.615575:0.920328:0.615575:0.920328:0.595512:0.085519:0.595512:0.005189:0.010640:0.009759:0.005356:0.006760:0.009759:0.004761:0.009640:0.009164:0.009188:0.009759:0.005379:0.010664:0.005284:0.005427:0.004761:0.010640:0.005213:0.004761:0.009164:0.015995:0.015900:0.009164:0.005094:0.010664:0.006760:0.009212:0.005427:0.009236:0.009259:0.005189:0.010664:0.009093:0.004761:0.010640:0.009759:0.009188:0.005427:0.009164:0.010711:0.010664:0.005379:0.009759:0.010616:0.010711:0.009164:0.010616:0.009236:0.009759:0.005379:0.005189:0.010640:0.009759:0.005356:0.009164:0.009236:0.005189:0.004761:0.009164:0.004665:0.005189:0.009212:0.005403:0.010664:0.005284:0.005427:0.004761:0.015900:0.015995:0.010687:0.010711:0.010664:0.009188:0.010592:0.010664:0.010664:0.006760:0.009688:0.009188:0.009188:0.004761:0.009069:0.009759:0.005356:0.009236:0.009759:0.004665:0.004761:0.009188:0.005260:0.005427:0.009164:0.004665:0.004761:0.010664:0.013377:0.004761:0.010616:0.010806:0.005951
tumor  cells  to  evade  immune  system  mechanisms.  Ki-67  is  a  protein  that  plays  a  role  in  the :@0.085519:0.638958:0.920222:0.638958:0.920222:0.618895:0.085519:0.618895:0.005189:0.010687:0.015900:0.010664:0.006760:0.005951:0.003975:0.009236:0.009759:0.004665:0.004761:0.009188:0.005951:0.004023:0.005189:0.010664:0.005951:0.003975:0.009759:0.009045:0.009164:0.010664:0.009688:0.005951:0.003999:0.004761:0.015900:0.015995:0.010687:0.010711:0.009640:0.005951:0.003999:0.009236:0.009212:0.009283:0.005189:0.009640:0.015995:0.005951:0.003975:0.015995:0.009664:0.009236:0.010711:0.009164:0.010711:0.004642:0.009236:0.015995:0.009188:0.005284:0.005951:0.003856:0.011806:0.005123:0.007982:0.010664:0.010664:0.005951:0.004046:0.004570:0.009236:0.005951:0.003999:0.009164:0.005951:0.003951:0.010664:0.006593:0.010664:0.005189:0.009664:0.004761:0.010640:0.005951:0.003999:0.005189:0.010640:0.009164:0.005094:0.005951:0.003999:0.010664:0.004856:0.009164:0.009212:0.009259:0.005951:0.003999:0.009164:0.005951:0.003951:0.006760:0.010664:0.004665:0.009759:0.005951:0.003927:0.004761:0.010640:0.005951:0.003999:0.005189:0.010711:0.009878:0.005951
proliferation of tumor cells, leading to a worse prognosis of the disease. Therefore, this study aimed :@0.085519:0.662340:0.920295:0.662340:0.920295:0.642277:0.085519:0.642277:0.010664:0.006760:0.010664:0.004761:0.004642:0.005213:0.009749:0.006760:0.009069:0.005189:0.004642:0.010664:0.010711:0.005713:0.010664:0.005284:0.005713:0.005189:0.010497:0.015995:0.010664:0.006760:0.005641:0.009236:0.009759:0.004665:0.004761:0.009188:0.005260:0.005713:0.004761:0.009640:0.009164:0.010664:0.004689:0.010545:0.010640:0.005760:0.005189:0.010664:0.005665:0.008974:0.005713:0.013377:0.010664:0.006593:0.009236:0.009759:0.005641:0.010664:0.006760:0.010521:0.010640:0.010711:0.010568:0.009236:0.004761:0.009188:0.005570:0.010664:0.005213:0.005641:0.005189:0.010640:0.009759:0.005641:0.010664:0.004761:0.009093:0.009759:0.009045:0.009236:0.009759:0.005213:0.005689:0.010640:0.010711:0.009759:0.006665:0.009759:0.005213:0.010664:0.006760:0.009640:0.005141:0.005713:0.004999:0.010711:0.004689:0.009236:0.005713:0.009236:0.005189:0.010497:0.010664:0.009259:0.005713:0.009164:0.004665:0.015995:0.009664:0.010664:0.005951
to determine the expression of TNFR2 and Ki-67 and their associations with the clinicopathological :@0.085519:0.685655:0.920363:0.685655:0.920363:0.665592:0.085519:0.665592:0.005189:0.010664:0.006212:0.010664:0.009759:0.005094:0.009759:0.006641:0.015995:0.004665:0.010711:0.009664:0.006379:0.005189:0.010640:0.009759:0.006331:0.009759:0.009474:0.010664:0.006760:0.009664:0.009236:0.009236:0.004761:0.010664:0.010521:0.006236:0.010664:0.005213:0.006189:0.010640:0.013020:0.010664:0.012163:0.010664:0.006260:0.009164:0.010711:0.010664:0.006212:0.011806:0.005002:0.007839:0.010664:0.010664:0.006308:0.008974:0.010711:0.010664:0.006260:0.005189:0.010640:0.009759:0.004642:0.006760:0.006189:0.009164:0.009188:0.009283:0.010664:0.009236:0.004761:0.009164:0.005094:0.004761:0.010664:0.010711:0.009188:0.006284:0.013377:0.004761:0.005094:0.010711:0.006236:0.005189:0.010640:0.009759:0.006189:0.009236:0.004761:0.004665:0.010711:0.004689:0.009236:0.010664:0.010711:0.009164:0.005094:0.010711:0.010664:0.004761:0.010664:0.010640:0.004761:0.009236:0.009164:0.004665:0.005951
features of young-onset colorectal cancer (YOCRC) in a single tertiary center. This retrospective :@0.085519:0.709037:0.920445:0.709037:0.920445:0.688975:0.085519:0.688975:0.005213:0.009759:0.009164:0.005094:0.010687:0.006760:0.009640:0.009236:0.008521:0.010664:0.005213:0.008331:0.009212:0.010711:0.010687:0.010545:0.010839:0.007982:0.010664:0.010568:0.009236:0.009759:0.005070:0.008521:0.009117:0.010664:0.004761:0.010664:0.006760:0.009616:0.009236:0.005189:0.009164:0.004642:0.008521:0.009236:0.009164:0.010711:0.009236:0.009688:0.006760:0.008474:0.006689:0.011949:0.013139:0.013092:0.011973:0.013163:0.006689:0.008497:0.004761:0.010640:0.008521:0.009164:0.008355:0.009236:0.004761:0.010640:0.010640:0.004761:0.009947:0.008552:0.005189:0.009497:0.006760:0.005070:0.004761:0.009069:0.006760:0.009212:0.008521:0.009236:0.009759:0.010711:0.005070:0.009759:0.006641:0.005213:0.008593:0.010640:0.010711:0.004761:0.009188:0.008569:0.006760:0.009640:0.005189:0.006641:0.010664:0.009259:0.010664:0.009759:0.009236:0.005189:0.004642:0.009164:0.009640:0.005951
study involved 36 patients (<50 years old) diagnosed with sporadic CRC between January 2013 and :@0.085519:0.732420:0.920400:0.732420:0.920400:0.712357:0.085519:0.712357:0.009236:0.005189:0.010687:0.010664:0.009212:0.005594:0.004761:0.010640:0.009164:0.010664:0.004689:0.009164:0.009640:0.010664:0.005594:0.010545:0.010664:0.005594:0.010664:0.009164:0.005118:0.004761:0.009640:0.010711:0.005118:0.009236:0.005570:0.006689:0.010664:0.010592:0.010664:0.005594:0.009117:0.009759:0.009045:0.006760:0.009188:0.005570:0.010664:0.004761:0.010664:0.006689:0.005570:0.010664:0.004761:0.009093:0.010640:0.010592:0.010664:0.009188:0.009664:0.010664:0.005594:0.013377:0.004761:0.005094:0.010711:0.005546:0.009236:0.010545:0.010664:0.006760:0.009093:0.010664:0.004761:0.009236:0.005403:0.013163:0.012068:0.013163:0.005498:0.010664:0.009759:0.005094:0.013377:0.009759:0.009640:0.010711:0.005546:0.009164:0.009164:0.010711:0.010687:0.009164:0.006760:0.009212:0.005546:0.010664:0.010568:0.010664:0.010664:0.005617:0.009164:0.010711:0.010330:0.005951
December 2023 at Hospital Universiti Sains Malaysia. TNFR2 and Ki-67 immunohistochemistry were :@0.085519:0.755802:0.920596:0.755802:0.920596:0.735739:0.085519:0.735739:0.013115:0.009759:0.009236:0.009640:0.015995:0.010664:0.009688:0.006760:0.005070:0.010664:0.010664:0.010711:0.010545:0.004999:0.009164:0.005094:0.005141:0.013139:0.010664:0.009236:0.010664:0.004761:0.005094:0.009164:0.004665:0.005141:0.013139:0.010711:0.004665:0.009164:0.009759:0.006760:0.009188:0.004761:0.005189:0.004642:0.005141:0.011901:0.009164:0.004761:0.010711:0.009188:0.005022:0.017043:0.009164:0.004761:0.009093:0.009212:0.009188:0.004761:0.009045:0.005213:0.005189:0.010640:0.013139:0.010664:0.012020:0.010664:0.005165:0.009164:0.010711:0.010664:0.004951:0.011806:0.004830:0.007982:0.010664:0.010664:0.005189:0.004761:0.015900:0.015995:0.010687:0.010521:0.010664:0.010711:0.004761:0.009188:0.005189:0.010521:0.009236:0.010711:0.009759:0.015900:0.004761:0.009188:0.005189:0.006665:0.009212:0.005189:0.013377:0.009759:0.006641:0.009759:0.005951
performed and evaluated using immunoreactive scoring. The data were analyzed using descriptive :@0.085519:0.779185:0.920207:0.779185:0.920207:0.759122:0.085519:0.759122:0.010664:0.009759:0.006665:0.005213:0.010735:0.006760:0.015900:0.009759:0.010664:0.007069:0.009164:0.010711:0.010473:0.007093:0.009545:0.009164:0.009069:0.004761:0.010687:0.009069:0.005260:0.009759:0.010664:0.007069:0.010687:0.009236:0.004761:0.010685:0.010640:0.007165:0.004570:0.015995:0.015995:0.010687:0.010640:0.010664:0.006760:0.009664:0.009164:0.009236:0.005189:0.004642:0.009164:0.009640:0.007093:0.009236:0.009236:0.010664:0.006760:0.004761:0.010616:0.010640:0.005213:0.007069:0.010640:0.010711:0.009569:0.007093:0.010664:0.009164:0.005118:0.009164:0.006927:0.013377:0.009759:0.006641:0.009759:0.007046:0.009164:0.010711:0.009069:0.004761:0.009212:0.008069:0.009759:0.010664:0.007117:0.010545:0.009188:0.004642:0.010711:0.010640:0.007141:0.010664:0.009569:0.009236:0.009236:0.006760:0.004665:0.010664:0.005189:0.004665:0.009164:0.009759:0.005951
statistics and Fischer's exact test, with P 0.05 considered significant. The results revealed that most :@0.085519:0.802567:0.920371:0.802567:0.920371:0.782504:0.085519:0.782504:0.009236:0.005189:0.009069:0.005189:0.004642:0.009236:0.005189:0.004642:0.009236:0.009259:0.005141:0.009164:0.010711:0.010664:0.005094:0.010664:0.004594:0.009236:0.009117:0.010711:0.009664:0.006760:0.004642:0.009236:0.005141:0.009759:0.009474:0.009164:0.009236:0.005189:0.005070:0.005189:0.009640:0.009236:0.005189:0.005213:0.004999:0.013377:0.004761:0.005094:0.010711:0.005118:0.011830:0.018014:0.010664:0.005213:0.010664:0.010664:0.005118:0.009117:0.010664:0.010568:0.009236:0.004761:0.010664:0.009664:0.006760:0.009640:0.010664:0.005165:0.009236:0.004761:0.010640:0.010711:0.004665:0.005213:0.004761:0.009236:0.009164:0.010545:0.005189:0.005213:0.005141:0.010640:0.010711:0.009759:0.005094:0.006760:0.009640:0.009236:0.010687:0.004761:0.005070:0.009236:0.005141:0.006760:0.009640:0.009164:0.009640:0.009164:0.004665:0.009759:0.010664:0.005094:0.005189:0.010640:0.009236:0.005189:0.005070:0.015995:0.010664:0.009188:0.005070:0.005951
≤:@0.415384:0.802769:0.433212:0.802769:0.433212:0.785921:0.415384:0.785921:0.017828
patients were female, with a predominance of Malays. The most common symptoms were altered :@0.085519:0.825849:0.920563:0.825849:0.920563:0.805786:0.085519:0.805786:0.010664:0.009164:0.005118:0.004761:0.009640:0.010711:0.005118:0.009236:0.007522:0.013377:0.009759:0.006641:0.009759:0.007474:0.005213:0.009759:0.015995:0.009093:0.004761:0.009640:0.005213:0.007593:0.013377:0.004761:0.005094:0.010711:0.007498:0.009164:0.007498:0.010664:0.006760:0.009664:0.010664:0.010664:0.015995:0.004761:0.010711:0.009069:0.010711:0.009236:0.009759:0.007474:0.010545:0.005213:0.007450:0.016971:0.009164:0.004665:0.009164:0.009212:0.009259:0.005213:0.007450:0.010640:0.010711:0.009759:0.007498:0.015995:0.010521:0.009236:0.005189:0.007331:0.009236:0.010664:0.015995:0.015995:0.010664:0.010711:0.007379:0.009188:0.009212:0.015995:0.010664:0.005118:0.010545:0.015995:0.009188:0.007569:0.013377:0.009759:0.006641:0.009759:0.007474:0.009164:0.005138:0.005189:0.009640:0.006760:0.009640:0.010806:0.005951
bowel habits and non-specific abdominal pain. The most frequently observed histological types were :@0.085519:0.849231:0.920483:0.849231:0.920483:0.829168:0.085519:0.829168:0.010664:0.010664:0.013425:0.009759:0.004642:0.005141:0.010711:0.009164:0.010664:0.004665:0.005189:0.009188:0.005141:0.009164:0.010711:0.010664:0.004951:0.010711:0.010664:0.010763:0.007982:0.009188:0.010664:0.009664:0.009236:0.004761:0.005213:0.004761:0.009236:0.005141:0.009164:0.010664:0.010521:0.010664:0.015995:0.004761:0.010616:0.009164:0.004665:0.005141:0.010664:0.009164:0.004689:0.010711:0.005213:0.005165:0.010640:0.010711:0.009759:0.005094:0.015995:0.010664:0.009188:0.005189:0.005141:0.005213:0.006760:0.009759:0.010664:0.010687:0.009664:0.010711:0.005118:0.004761:0.009212:0.005118:0.010545:0.010664:0.009259:0.009759:0.006641:0.009164:0.009640:0.010664:0.005165:0.010711:0.004689:0.009236:0.005189:0.010664:0.004665:0.010664:0.010687:0.004570:0.009236:0.009164:0.004761:0.005070:0.005189:0.009212:0.010664:0.009759:0.009188:0.005165:0.013377:0.009759:0.006641:0.009759:0.005951
conventional adenocarcinoma, signet ring cell carcinoma, mucinous, and neuroendocrine carcinoma. :@0.085519:0.872613:0.920352:0.872613:0.920352:0.852551:0.085519:0.852551:0.009236:0.010664:0.010711:0.009164:0.009688:0.010711:0.005118:0.004761:0.010664:0.010711:0.009069:0.004761:0.004499:0.009164:0.010664:0.009688:0.010711:0.010664:0.009236:0.009164:0.006760:0.009236:0.004665:0.010711:0.010664:0.015995:0.009164:0.005213:0.004404:0.009236:0.004761:0.010497:0.010711:0.009664:0.005189:0.004499:0.006760:0.004642:0.010711:0.010640:0.004594:0.009236:0.009759:0.004665:0.004761:0.004499:0.009236:0.009164:0.006689:0.009236:0.004761:0.010711:0.010664:0.015995:0.009069:0.005213:0.004618:0.015995:0.010687:0.009236:0.004761:0.010497:0.010664:0.010687:0.009188:0.005094:0.004570:0.009164:0.010711:0.010664:0.004523:0.010711:0.009664:0.010687:0.006760:0.010664:0.009664:0.010711:0.010664:0.010545:0.009236:0.006760:0.004665:0.010711:0.009664:0.004570:0.009236:0.009164:0.006689:0.009236:0.004761:0.010711:0.010664:0.015995:0.009069:0.005213:0.005951
The majority of cases were diagnosed at stages III and IV, featuring moderately differentiated tumors, :@0.085519:0.895996:0.920474:0.895996:0.920474:0.875933:0.085519:0.875933:0.010640:0.010711:0.009759:0.005094:0.015995:0.009093:0.004975:0.010664:0.006760:0.004689:0.005189:0.009212:0.005118:0.010664:0.005284:0.005141:0.009117:0.009164:0.009188:0.009759:0.009188:0.005165:0.013377:0.009759:0.006641:0.009759:0.005070:0.010664:0.004761:0.009093:0.010640:0.010711:0.010568:0.009236:0.009759:0.010664:0.005094:0.009164:0.005094:0.005141:0.009236:0.005189:0.009069:0.010640:0.009759:0.009188:0.005189:0.005332:0.005213:0.005332:0.005070:0.009164:0.010711:0.010796:0.005131:0.005332:0.011901:0.005260:0.004999:0.005213:0.009759:0.009164:0.005094:0.010687:0.006760:0.004642:0.010711:0.010640:0.005165:0.015995:0.010664:0.010664:0.009759:0.006641:0.009164:0.005094:0.009759:0.004642:0.009212:0.005189:0.010664:0.004761:0.005213:0.005284:0.009759:0.006641:0.009759:0.010616:0.005189:0.004642:0.009164:0.005189:0.009759:0.010664:0.005141:0.005189:0.010687:0.015900:0.010664:0.006760:0.009188:0.005284:0.005951
predominantly situated on the left side. No significant links were found between TNFR2 expression :@0.085519:0.919378:0.919995:0.919378:0.919995:0.899315:0.085519:0.899315:0.010664:0.006760:0.009664:0.010664:0.010664:0.015995:0.004761:0.010711:0.009069:0.010711:0.005118:0.004761:0.009212:0.006379:0.009236:0.004761:0.005070:0.010687:0.009164:0.005094:0.009759:0.010664:0.006355:0.010664:0.010711:0.006403:0.005189:0.010640:0.009759:0.006331:0.004832:0.009759:0.005213:0.005189:0.006474:0.009236:0.004761:0.010664:0.009664:0.005213:0.006450:0.013139:0.010664:0.006236:0.009236:0.004761:0.010640:0.010711:0.004665:0.005213:0.004761:0.009236:0.009021:0.010711:0.005118:0.006379:0.004761:0.004642:0.010711:0.009164:0.009188:0.006403:0.013377:0.009759:0.006641:0.009759:0.006331:0.005213:0.010735:0.010687:0.010711:0.010664:0.006403:0.010664:0.009759:0.005094:0.013377:0.009759:0.009640:0.010711:0.006379:0.010640:0.013139:0.010664:0.012163:0.010664:0.006427:0.009759:0.009474:0.010664:0.006760:0.009664:0.009236:0.009236:0.004570:0.010664:0.010711:0.005951